Research graph
References from Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients. Local targets link to admitted publications; unresolved targets remain external evidence.
Monitoring the decrease in breast cancer mortality in Europe
10.1097/00008469-200512000-00002 · 2005 · External reference
Impact of metastatic estrogen receptor and progesterone receptor status on survival
10.1007/s10549-004-2756-z · 2005 · External reference
Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer
10.1309/ajcpd1ao3ysyqynw · 2008 · External reference
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
10.1093/annonc/mdp263 · 2009 · External reference
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
10.1093/annonc/mdp427 · 2010 · External reference
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
10.1186/bcr2771 · 2010 · External reference
Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency
10.1186/bcr86 · 2000 · External reference
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
10.1038/sj.bjc.6603584 · 2007 · External reference
Strategies for the discovery and development of therapies for metastatic breast cancer
10.1038/nrd2372 · 2012 · External reference
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis
10.1158/1078-0432.ccr-09-1192 · 2010 · External reference
CTCs in metastatic breast cancer
10.1007/978-3-642-28160-0_18 · 2012 · External reference
Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients
2012 · External reference
Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment
10.1007/s10555-012-9366-8 · 2012 · External reference
Minimal residual disease and circulating tumor cells in breast cancer
10.1186/bcr2906 · 2011 · External reference
Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?
10.1093/annonc/mds111 · 2012 · External reference
Considerations in the development of circulating tumor cell technology for clinical use
10.1186/1479-5876-10-138 · 2012 · External reference
Circulating tumor cells: approaches to isolation and characterization
10.1083/jcb.201010021 · 2011 · External reference
Clinical significance of circulating tumor cells in breast cancer patients
10.1007/s10549-011-1512-4 · 2011 · External reference
Circulating tumor cells: not all detected cells are bad and not all bad cells are detected
10.1200/jco.2010.34.0026 · 2011 · External reference
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
10.1056/nejmoa040766 · 2004 · External reference
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
10.1200/jco.2005.08.140 · 2005 · External reference
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
10.1007/s10549-008-0143-x · 2009 · External reference
Circulating tumor cells in breast cancer: a tool whose time has come of age
10.1186/1741-7015-9-43 · 2011 · External reference
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “liquid biopsy”: trastuzumab in HER2/neu-positive breast carcinoma
10.1007/s00432-011-1000-6 · 2011 · External reference
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
10.1007/s00432-010-0942-4 · 2010 · External reference
Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines
10.1371/journal.pone.0033788 · 2012 · External reference
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
10.1007/s10549-005-9147-y · 2006 · External reference
ERalphastatus of disseminated tumour cells in bone marrow of primary breast cancer patients
10.1186/bcr2143 · 2008 · External reference
HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor
2009 · External reference
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer
10.3816/cbc.2010.n.052 · 2010 · External reference
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
10.1186/bcr2349 · 2009 · External reference
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
10.1007/s10549-010-1163-x · 2010 · External reference
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
10.1158/1078-0432.ccr-09-2042 · 2010 · External reference
HER2-positive circulating tumor cells in breast cancer
10.1371/journal.pone.0015624 · 2011 · External reference
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
10.1002/cncr.22076 · 2006 · External reference
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
10.1002/cncr.11066 · 2003 · External reference
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature
10.1517/14656566.2011.537260 · 2011 · External reference
Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells
10.1186/1756-8722-1-2 · 2008 · External reference
Reassessment of estrogen receptor expression in human breast cancer cell lines
2011 · External reference
Cell cycle proteins in epithelial cell differentiation: implications for breast cancer
10.4161/cc.9.10.11474 · 2010 · External reference
Biological determinants of endocrine resistance in breast cancer
10.1038/nrc2713 · 2009 · External reference
Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells
10.1158/1078-0432.ccr-11-2100 · 2012 · External reference
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
10.1002/ijc.25690 · 2011 · External reference
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
10.1007/s10549-011-1508-0 · 2011 · External reference
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
10.1073/pnas.1012539107 · 2010 · External reference
Microparticles and their emerging role in cancer multidrug resistance
10.1016/j.ctrv.2011.06.005 · 2011 · External reference
Portable filter-based microdevice for detection and characterization of circulating tumor cells
10.1158/1078-0432.ccr-10-1105 · 2010 · External reference
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer
10.1126/scitranslmed.3000403 · 2010 · External reference
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
10.1158/1078-0432.ccr-06-0169 · 2006 · External reference
Triple immunofluorescence staining with antibodies raised in the same species to study the complex innervation pattern of intrapulmonary chemoreceptors
10.1177/002215540205000415 · 2002 · External reference
